A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence in Denmark ... Novo Nordisk has ...

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

Novo Nordisk launches a new cash-pay option for a leading diabetes drug, changing affordability dynamics for uninsured ...

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

Europe is a major manufacturing hub for brand-name drugs in particular, including the blockbuster drug Ozempic.

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...